维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="FARTOUX L"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma:results of a multicenter phase 2 study显示文摘	Asnacios A Fartoux L Romano O		0，，12：	2
2	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells显示文摘	Marie-José Blivet-Van Eggelpo?l Hamza Chettouh Laetitia Fartoux Lynda Aoudjehane Véronique Barbu Colette Rey Sabrina Priam Chantal Housset Olivier Rosmorduc Christèle Desbois-Mouthon	2012	Journal of Hepatology2012，，1：	2
3	The diffusion- weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellu- lar carcinoma: a pilot study显示文摘	Lewin M Fartoux L Vignaud A	2011	Eur Radiol2011，21，2：	1
4	Gemcitabine plus oxali- platin (GEMOX) combined with cetuximab in patients with pro- gressive advanced stage hepatocellular carcinoma : results of a mul- ticenter phase 2study显示文摘	Asnaeios A Fartoux L Romano O	2008	Cancer2008，112，12：	1
5	Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: resuits of a multicenter phase 2 study 显示文摘	Asnacios A Fartoux L Romano O	2008	Cancer2008，112，12：	1
6	Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma:results of a multicenter phase 2 study显示文摘	Asnacios A Fartoux L Romano O	2008	Cancer2008，112，：	1
7	The diffusion-weighted ima- ging peffusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma:a pilot study显示文摘	Lewin M Fartoux L Vignaud A	2011	Eur Radiol2011，21，：	1
8	The diffusion-weighted imaging perfusion fraction a potential marker of sorafenib treatment in advanced epatocellular carcinoma: a pilot study 显示文摘	Lewin M Fartoux L Vignaud A	2011	Eur Radiol2011，21，2：	1
9	A multicenter, rarldomized phase Ⅱ trial of gemcitabine and oxaliplatin alone or in combina- tion with biweekly cetuximab in the ftrst line treatment of advanced biliary cancer: An interim analysis of the BINGO trial显示文摘	Malka D Trarbach T Fartoux L	2009	J Clin On- col2009，27，7：	1
10	Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors 显示文摘	Chettouh H Fartoux L Aoudjehane L	2013	Cancer Res2013，73，13：	1
11	Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection 显示文摘	Fartoux L Arrive L Andreani T	2005	Gastroenterol Clin Biol2005，29，12：	1
12	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells显示文摘	Blivet-Van Eggelpoel MJ Chettouh H Fartoux L	2012	J Hepatol2012，57，1：	1
13	A multicenter, randomized phase Ⅱ trial of gemcitabine and oxaliplatin (GEMOX) alone or in combination with biweekly cetuximab in the first-line treatment of advanced biliary cancer : interim analysis of the BINGO trial 显示文摘	Malka D Trarbach T Fartoux L	2009	J Clin Oncol2009，27，15：	1
14	Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors显示文摘	Chettouh H Fartoux L Aoudjehane L		0，，13：	1
15	Impact of steatosis on progression of fibrosis in patients with mild hepatitis C 显示文摘	FARTOUX L CHAZOUILLERES O WENDUM D	2005	Hepatology2005，32，41：	1
16	Treament of small hepatocellular carcinoma with acetic percutaneous injection 显示文摘	Fartoux I Arrivel L Andreani T	2005	Gastroenterol Clin Biol2005，29，12：	1
17	Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection显示文摘	Fartoux L Arrive L Andreani T	2005	Gastroenterol Clin Biol2005，29，12：	1
18	Impact of steatosis on progression of fibrosis in patients with mild hepatitis C显示文摘	Fartoux L Chazouilleres O Wendum D	2005	Hepatology2005，41，1：	1
19	Gemcitabine and ox- aliplatin in advanced hiliary tract carcinoma: A phase II study 显示文摘	Andr6 T Reyes - Vidal JM Fartoux L	2008	Br J Cancer2008，99，6：	1
20	PET/CT in patients with hep- atocellar carcinoma using fluorecholine: preliminary compari- son with FDG PET/CT显示文摘	Talbot JN Gutman F Fartoux L	2006	Eur J Nucl Med Mol Imaging2006，33，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示